PrEP reduces HIV infections by over 95% in US ‘real world’ study
High prevalence of stockouts of antiretroviral medicines in South Africa
Rapid adoption of generic HIV drugs could save NHS £7 billion by 2033
Two-drug protease inhibitor treatment as effective as three-drug treatment – and fewer stop due to side-effects
Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds
Donor funding for HIV stalls, increasing pressure on high-burden countries to mobilise domestic resources
NHS England saved £10 million by switching to generic anti-HIV drugs in 2016
